These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27291621)

  • 1. Use of telemedicine in inflammatory bowel disease: a real monitoring option?
    Aguas M; Del Hoyo J; Faubel R; Nos P
    Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):879-81. PubMed ID: 27291621
    [No Abstract]   [Full Text] [Related]  

  • 2. E-health in inflammatory bowel diseases: More challenges than opportunities?
    Bossuyt P; Pouillon L; Bonnaud G; Danese S; Peyrin-Biroulet L
    Dig Liver Dis; 2017 Dec; 49(12):1320-1326. PubMed ID: 28899622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Patil SA; Cross RK
    Inflamm Bowel Dis; 2018 Aug; 24(9):1910-1917. PubMed ID: 29718218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telemedicine in inflammatory bowel disease: opportunities and approaches.
    Aguas Peris M; Del Hoyo J; Bebia P; Faubel R; Barrios A; Bastida G; Valdivieso B; Nos P
    Inflamm Bowel Dis; 2015 Feb; 21(2):392-9. PubMed ID: 25437818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote Monitoring and Telemedicine in IBD: Are We There Yet?
    George LA; Cross RK
    Curr Gastroenterol Rep; 2020 Feb; 22(3):12. PubMed ID: 32040650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial.
    Cross RK; Jambaulikar G; Langenberg P; Tracy JK; Collins JF; Katz J; Regueiro M; Schwartz DA; Quinn CC
    Contemp Clin Trials; 2015 May; 42():132-44. PubMed ID: 25812483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile Health Application Solutions.
    Saxon LA
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e002477. PubMed ID: 26810595
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Bilgrami Z; Abutaleb A; Chudy-Onwugaje K; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Ghazi L; Patil SA; Quezada SM; Russman KM; Quinn CC; Jambaulikar G; Beaulieu DB; Horst S; Cross RK
    Dig Dis Sci; 2020 Jan; 65(1):96-103. PubMed ID: 30604373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.
    de Jong M; van der Meulen-de Jong A; Romberg-Camps M; Degens J; Becx M; Markus T; Tomlow H; Cilissen M; Ipenburg N; Verwey M; Colautti-Duijsens L; Hameeteman W; Masclee A; Jonkers D; Pierik M
    Inflamm Bowel Dis; 2017 Apr; 23(4):485-493. PubMed ID: 28267047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gomollón F
    Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():14-19. PubMed ID: 27888859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of telemanagement is high in patients with inflammatory bowel disease.
    Cross RK; Arora M; Finkelstein J
    J Clin Gastroenterol; 2006 Mar; 40(3):200-8. PubMed ID: 16633120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study.
    Cross RK; Finkelstein J
    Dig Dis Sci; 2007 Feb; 52(2):357-64. PubMed ID: 17211702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers.
    Del Hoyo J; Millán M; Garrido-Marín A; Aguas M
    World J Gastroenterol; 2023 Feb; 29(7):1139-1156. PubMed ID: 36926667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telemedicine in the treatment of patients with inflammatory bowel disease.
    Aguas M; Del Hoyo J; Faubel R; Valdivieso B; Nos P
    Gastroenterol Hepatol; 2017 Nov; 40(9):641-647. PubMed ID: 28797518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ["Doc2Patient" -16 years' experience of the Medical Online Consultation Service at the University Hospital Zurich].
    Schmidt-Weitmann S; Buser J; Baumann D; Schmidt C; Brockes C
    Ther Umsch; 2015 Sep; 72(9):549-52. PubMed ID: 26323952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches need to integrate technology.
    Health Care Strateg Manage; 2000 Mar; 18(3):20. PubMed ID: 10787665
    [No Abstract]   [Full Text] [Related]  

  • 19. Telemedicine in Inflammatory Bowel Disease: Opportunity Ahead.
    Aguas M; Del Hoyo J; Faubel R; Nos P
    Inflamm Bowel Dis; 2016 Feb; 22(2):E4-5. PubMed ID: 26752472
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease-related knowledge in inflammatory bowel disease: experience of a tertiary care centre in a developing country in South Asia.
    Subasinghe D; Wijekoon NS; Nawarathne NM; Samarasekera DN
    Singapore Med J; 2010 Jun; 51(6):484-9. PubMed ID: 20658108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.